Substance P/Neurokinin-1 Receptor Antagonist
37 drugs across 17 manufacturers|35 Generic,2 Brand
The Substance P/Neurokinin-1 Receptor Antagonist class contains 37 NDCs from 17 manufacturers (35 generic, 2 brand), at an average NADAC of $68.98 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
37
35G / 2B
Manufacturers
17
Avg $68.9828/unit
Avg 7d Change
+3.51%
Across 21 drugs with changes
7d Activity
of 37 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
17 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 5 more manufacturers
Frequently Asked Questions
How many drugs are in the Substance P/Neurokinin-1 Receptor Antagonist class?
The Substance P/Neurokinin-1 Receptor Antagonist class contains 37 NDCs from 17 manufacturers — 35 generic and 2 brand products.
What is the average price of Substance P/Neurokinin-1 Receptor Antagonist drugs?
The average NADAC for the Substance P/Neurokinin-1 Receptor Antagonist class is $68.9828 per unit across 37 NDCs.
Is generic cheaper than brand in the Substance P/Neurokinin-1 Receptor Antagonist class?
Among products priced per EA, the average generic NADAC in this class is $57.5999, versus $268.1835 for brand — brand products average about 4.7× the generic price.
Which manufacturers make Substance P/Neurokinin-1 Receptor Antagonist drugs?
17 manufacturers make drugs in the Substance P/Neurokinin-1 Receptor Antagonist class. Ranked by number of NDCs, the largest are BluePoint Laboratories (6), Sandoz Inc. (5), Torrent Pharmaceuticals Limited (5), Glenmark Pharmaceuticals Inc., USA (5), Merck Sharp & Dohme LLC (2).
How has Substance P/Neurokinin-1 Receptor Antagonist pricing changed recently?
Over the past 7 days, 16 NDCs in this class rose and 5 fell, with a class-wide average change of +3.5%.